IN THE STATES: Biden Continues Working to Lower Prescription Drug Prices

In the states this week, local news highlighted how President Biden continues working  to deliver on lowering prescription drug costs, with news that two more major drug companies, Novo Nordisk and Sanofi, are heeding President Biden’s call to cap the price of insulin at $35 a month in line with the Inflation Reduction Act. Sanofi and Novo Nordisk’s actions follow similar decisions by drug manufacturer Eli Lilly, which combined, make up 90% of the insulin market in the United States.

On Wednesday, President Biden traveled to Nevada to discuss how the administration is working to lower costs and building on the progress Democrats made with the Inflation Reduction Act in capping insulin costs for seniors on Medicare at $35 a month. The president also called on MAGA Republicans to stop obstructing and work together to help lower costs. 

Here’s what Nevadans are reading about President Biden’s work to lower the cost of life-saving prescription drugs for seniors and working families: 

Also this week, President Biden traveled to California to discuss taking action to reduce gun violence with an executive order to increase the number of background checks conducted before firearm sales.

And Vice President Harris called out Republicans’ latest extreme attacks on reproductive rights, which endanger women’s health, with an impact that goes far beyond reproductive health care.

Not to be missed – local news in Nevada also highlighted Ron DeSantis’s support for creating a nuclear wasteland at Yucca Mountain in Nevada as the presidential hopeful traveled to the state last weekend.